Maple Securities USA’s Bristol-Myers Squibb BMY Stock Holding History

Maple Securities USA’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-9,945	Closed	-$641K	–	244
2015 Q1	$641K	Buy	+9,945	New	+$623K	0.05%	87
2014 Q3	–	Sell	-5,499	Closed	-$267K	–	228
2014 Q2	$267K	Sell	5,499 -142,564	-96%	-$7.03M	0.03%	170
2014 Q1	$7.69M	Buy	148,063 +124,878	+539%	+$6.64M	0.68%	13
2013 Q4	$1.23M	Sell	23,185 -77,856	-77%	-$3.97M	0.09%	93
2013 Q3	$4.68M	Buy	101,041 +8,351	+9%	+$367K	0.37%	52
2013 Q2	$4.14M	Buy	+92,690	New	+$4.02M	0.38%	59

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Maple Securities USA's BMY Position: Q2 2015 in Review

Maple Securities USA sold out of Bristol-Myers Squibb (BMY) in Q2 2015, closing a stake of 9,945 shares — an estimated $641K sold.

Maple Securities USA first reported a position in BMY in Q2 2013 and held it in 6 quarters. The position peaked at $7.69M in Q1 2014. 1,446 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

Maple Securities USA reported no remaining Bristol-Myers Squibb position as of Q2 2015 after selling out during the quarter.
Maple Securities USA sold 9,945 Bristol-Myers Squibb shares in Q2 2015, an estimated $641K.
Maple Securities USA first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 6 quarters.
Maple Securities USA's Bristol-Myers Squibb position peaked at $7.69M in Q1 2014.
1,446 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Maple Securities USA's 13F filing for Q2 2015, filed 24 Jul 2015.